Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
Globe Newswire (Thu, 9-Apr 8:00 AM ET)
Goldman Sachs Sticks to Its Hold Rating for Kestra Medical Technologies Ltd. (KMTS)
TipRanks (Wed, 8-Apr 4:36 PM ET)
Kestra Medical Technologies Ltd. (KMTS) Gets a Buy from BTIG
TipRanks (Tue, 7-Apr 7:37 AM ET)
Kestra Medical Technologies Named Finalist for 2026 GeekWire "Deal of the Year"
Globe Newswire (Wed, 25-Mar 8:00 AM ET)
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
Globe Newswire (Tue, 17-Mar 4:01 PM ET)
Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17
Globe Newswire (Tue, 3-Mar 6:00 AM ET)
Globe Newswire (Tue, 13-Jan 6:00 AM ET)
Market Chameleon (Wed, 3-Dec 5:34 AM ET)
KMTS to Reveal Q2 Fiscal 2026 Results: Key Dates and What Investors Should Watch
Market Chameleon (Wed, 3-Dec 3:59 AM ET)
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of April 9, 2026, KMTS stock price declined to $19.25 with 225,040 million shares trading.
KMTS has a beta of 1.12, meaning it tends to be more sensitive to market movements. KMTS has a correlation of 0.09 to the broad based SPY ETF.
KMTS has a market cap of $1.12 billion. This is considered a Small Cap stock.
Last quarter Kestra Medical Techs reported $25 million in Revenue and -$.61 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.01.
The top ETF exchange traded funds that KMTS belongs to (by Net Assets): VTI, IWM, IWO, VXF, VTWO.
KMTS has underperformed the market in the last year with a price return of -11.7% while the SPY ETF gained +38.4%. KMTS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.8% and -6.5%, respectively, while the SPY returned -1.1% and +3.5%, respectively.
KMTS support price is $18.52 and resistance is $20.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.